240 related articles for article (PubMed ID: 25694518)
1. Gene expression profiling of Burkholderia cenocepacia at the time of cepacia syndrome: loss of motility as a marker of poor prognosis?
Kalferstova L; Kolar M; Fila L; Vavrova J; Drevinek P
J Clin Microbiol; 2015 May; 53(5):1515-22. PubMed ID: 25694518
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Cystic Fibrosis Sputum Medium Regulates Flagellar Biosynthesis through the flhF Gene in Burkholderia cenocepacia.
Kumar B; Cardona ST
Front Cell Infect Microbiol; 2016; 6():65. PubMed ID: 27379216
[TBL] [Abstract][Full Text] [Related]
3. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
Drevinek P; Mahenthiralingam E
Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
[TBL] [Abstract][Full Text] [Related]
4. A c-di-GMP-Modulating Protein Regulates Swimming Motility of
Kumar B; Sorensen JL; Cardona ST
Front Cell Infect Microbiol; 2018; 8():56. PubMed ID: 29541628
[No Abstract] [Full Text] [Related]
5. The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.
Loeven NA; Perault AI; Cotter PA; Hodges CA; Schwartzman JD; Hampton TH; Bliska JB
mBio; 2021 Oct; 12(5):e0209821. PubMed ID: 34579569
[TBL] [Abstract][Full Text] [Related]
6. What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics.
Nunvar J; Capek V; Fiser K; Fila L; Drevinek P
PLoS Pathog; 2017 Dec; 13(12):e1006762. PubMed ID: 29228063
[TBL] [Abstract][Full Text] [Related]
7. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
St Denis M; Ramotar K; Vandemheen K; Tullis E; Ferris W; Chan F; Lee C; Slinger R; Aaron SD
Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
[TBL] [Abstract][Full Text] [Related]
8. Whole-Genome Sequencing of Three Clonal Clinical Isolates of B. cenocepacia from a Patient with Cystic Fibrosis.
Miller RR; Hird TJ; Tang P; Zlosnik JE
PLoS One; 2015; 10(11):e0143472. PubMed ID: 26599356
[TBL] [Abstract][Full Text] [Related]
9. Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum.
Drevinek P; Holden MT; Ge Z; Jones AM; Ketchell I; Gill RT; Mahenthiralingam E
BMC Infect Dis; 2008 Sep; 8():121. PubMed ID: 18801206
[TBL] [Abstract][Full Text] [Related]
10. Novel diagnostic PCR assay for Burkholderia cenocepacia epidemic strain ST32 and its utility in monitoring infection in cystic fibrosis patients.
Dedeckova K; Kalferstova L; Strnad H; Vavrova J; Drevinek P
J Cyst Fibros; 2013 Sep; 12(5):475-81. PubMed ID: 23317764
[TBL] [Abstract][Full Text] [Related]
11. The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis.
Zlosnik JE; Speert DP
J Infect Dis; 2010 Sep; 202(5):770-81. PubMed ID: 20670172
[TBL] [Abstract][Full Text] [Related]
12. Insights into the genome diversity and virulence of two clinical isolates of Burkholderia cenocepacia.
Salloum T; Nassour E; Araj GF; Abboud E; Tokajian S
J Med Microbiol; 2018 Aug; 67(8):1157-1167. PubMed ID: 29897328
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
[TBL] [Abstract][Full Text] [Related]
14. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
[TBL] [Abstract][Full Text] [Related]
15. Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions.
Guadalupe Cabral M; Pereira M; Silva Z; Iria I; Coutinho C; Lopes A; Sá-Correia I; Videira PA
Med Microbiol Immunol; 2017 Apr; 206(2):111-123. PubMed ID: 27987042
[TBL] [Abstract][Full Text] [Related]
16. Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology.
Vasiljevic ZV; Novovic K; Kojic M; Minic P; Sovtic A; Djukic S; Jovcic B
Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1277-84. PubMed ID: 27177755
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic diversity and genotypic flexibility of
Lee AH; Flibotte S; Sinha S; Paiero A; Ehrlich RL; Balashov S; Ehrlich GD; Zlosnik JE; Mell JC; Nislow C
Genome Res; 2017 Apr; 27(4):650-662. PubMed ID: 28325850
[TBL] [Abstract][Full Text] [Related]
18. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.
Nunvar J; Kalferstova L; Bloodworth RA; Kolar M; Degrossi J; Lubovich S; Cardona ST; Drevinek P
PLoS One; 2016; 11(8):e0160975. PubMed ID: 27512997
[TBL] [Abstract][Full Text] [Related]
20. Burkholderia cenocepacia differential gene expression during host-pathogen interactions and adaptation to the host environment.
O'Grady EP; Sokol PA
Front Cell Infect Microbiol; 2011; 1():15. PubMed ID: 22919581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
